Inclusion Criteria:

• 1. Participants who develop early onset visible dry skin or atopic dermatitis up to and equal to 12 weeks of age.
• 2. Stated willingness to comply with all study procedures and availability for the duration of the study
• 3. In good general health as evidenced by medical history
• 4. No known adverse reaction to any of the study medications, their components or excipients

Exclusion Criteria:

• 1. Infants \<3kg body weight
• 2. Infants with a chronic disease requiring therapy (e.g. heart disease, diabetes, serious neurological defects, immunodeficiency)
• 3. Known moderate to severe cutaneous skin disorder other than AD, including but not limited to cutaneous mastocytosis, bullous skin disease, pustular skin disease, neonatal HSV, aplasia, and albinism
• 4. Parents or guardians unwilling to sign consent
• 5. Current participant or participation since birth in any interventional study
• 6. Investigator or designee considers that the participant or parent/guardian would be unsuitable for inclusion in the study (for ex/ long stay in NICU)
• 7. A course of antibiotics in infant within 7 days of enrollment
• 8. Any known food allergies